[Determination of the viability of preserved bone marrow in transplantation to oncological patients].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects / Q000528:radiation effects; D016026:Bone Marrow Transplantation; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D005615:Freezing; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012516:Osteosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011832:Radiation Injuries / Q000517:prevention & control*; D011878:Radiotherapy / Q000009:adverse effects*; D014021:Tissue Preservation; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents
Opredelenie zhiznesposobnosti konservirovannogo kostnogo mozga pri transplantatsii onkologicheskim bol'nym.